作者:Xiao-bao Shen、Yang Wang、Xuan-zhen Han、Liang-quan Sheng、Fu-fang Wu、Xinhua Liu
DOI:10.1080/14756366.2020.1740693
日期:2020.1.1
were designed and synthesised. With the help of reverse targets searching, anti-cancer activity was preliminarily evaluated, most of them are effective against some tumour cells, especially compound 12: 1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl-4-oxo-4-((4-phenoxyphenyl)amino) butanoate whose IC50 against SGC-7901 was 4.1 ± 2.6 μM. Meanwhile the anticancer mechanism
摘要 基于萘醌部分的分子对接和药效团分析,总共设计和合成了23种化合物。借助反向靶标搜索,初步评估了其抗癌活性,其中大多数对某些肿瘤细胞有效,尤其是化合物12:1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen -2-基)-4-甲基戊-3-烯-1-基-4-氧代-4-((4-苯氧基苯基)氨基)丁酸酯,其对SGC-7901的IC 50为4.1±2.6μM。同时通过AnnexinV / PI染色,免疫荧光,Western印迹分析和分子对接研究了化合物12的抗癌机理。结果表明该化合物可能通过调节PI3K信号通路诱导细胞凋亡和细胞自噬。